| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-10 |
| mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-09 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |